Embecta EMBC
NASDAQ EMBC
$6.86 +0.18 (+2.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Embecta (EMBC) Return on Equity [ROE] (2021)

Updated

Embecta's Return on Equity [ROE] was 71.33% in fiscal Q1 2022 (quarter ended Dec 31, 2021), up 0.49 percentage points from the prior quarter.

Analysis

Embecta (EMBC) Return on Equity [ROE] (2021) Analysis & Trends

For FY2021 (ended Sep 30, 2021), Return on Equity [ROE] at Embecta came in at 71.12%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn 10.39%
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn 17.28%
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn 10.44%
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn -3.90%
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn 14.31%
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn 3.88%
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn 9.53%
10 Embecta 398.83 Mn -427.57 Mn 153.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 71.33%
Sep 30, 2021 70.85%
API Access

Embecta Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EMBC&period=max&api_key=YOUR_API_KEY